2021 G-CAN 共识声明：慢性肾脏病痛风的管理

2021-07-30 痛风、高尿酸血症和晶体相关疾病网络（Gout, Hyperuricemia and Crystal-Associated Disease Network, G-CAN） Nat Rev Rheumatol . 2021 Jul 30.

痛风和慢性肾病 (CKD) 经常共存，但缺乏指导 CKD 患者痛风管理的质量证据。在晚期 CKD 背景下使用降尿酸治疗 (ULT) 差异很大，专业机构就合并 CKD 患者的痛风治疗发表了相互矛盾的建议

中文标题：

英文标题：

Management of gout in chronic kidney disease: a G-CAN Consensus Statement on the research priorities

发布机构：

发布日期：

2021-07-30

简要介绍：

痛风和慢性肾病 (CKD) 经常共存，但缺乏指导 CKD 患者痛风管理的质量证据。在晚期 CKD 背景下使用降尿酸治疗 (ULT) 差异很大，专业机构就合并 CKD 患者的痛风治疗发表了相互矛盾的建议。因此，医疗专业人员对痛风和 CKD 患者的适当管理存在混淆。痛风、高尿酸血症和晶体相关疾病网络 (G-CAN) 的这份共识声明讨论了 CKD 患者痛风管理的证据和/或缺乏证据，并确定了研究的关键领域，以解决管理中面临的挑战痛风和 CKD。这些讨论涉及一般研究领域以及与用于治疗痛风发作或作为 ULT 的特定药物相关的研究领域，得到单独发表的 G-CAN 系统文献综述的支持。本共识声明并非旨在作为 CKD 痛风管理的指南；相反，它分析了有关用于痛风管理的药物的安全性和有效性的现有文献，以确定知识和相关研究领域的重要差距。

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=7dead1c0021a4e0e, title=2021 G-CAN 共识声明：慢性肾脏病痛风的管理, enTitle=Management of gout in chronic kidney disease: a G-CAN Consensus Statement on the research priorities, guiderFrom=Nat Rev Rheumatol . 2021 Jul 30., authorId=0, author=, summary=痛风和慢性肾病 (CKD) 经常共存，但缺乏指导 CKD 患者痛风管理的质量证据。在晚期 CKD 背景下使用降尿酸治疗 (ULT) 差异很大，专业机构就合并 CKD 患者的痛风治疗发表了相互矛盾的建议, cover=https://img.medsci.cn/202182/1627836129678_2020535.jpg, journalId=0, articlesId=null, associationId=1947, associationName= 痛风、高尿酸血症和晶体相关疾病网络（Gout, Hyperuricemia and Crystal-Associated Disease Network, G-CAN）, associationIntro=G-CAN, copyright=0, guiderPublishedTime=Fri Jul 30 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="bp3-card bp3-elevation-0 result-block" style="color: #182026;"> <div class="bp3-collapse"> <div class="bp3-collapse-body bp3-fixed-positioning-containing-block" aria-hidden="false"> <div class="common-result"> <div class="general-result"> <p>痛风和慢性肾病 (CKD) 经常共存，但缺乏指导 CKD 患者痛风管理的质量证据。在晚期 CKD 背景下使用降尿酸治疗 (ULT) 差异很大，专业机构就合并 CKD 患者的痛风治疗发表了相互矛盾的建议。因此，医疗专业人员对痛风和 CKD 患者的适当管理存在混淆。痛风、高尿酸血症和晶体相关疾病网络 (G-CAN) 的这份共识声明讨论了 CKD 患者痛风管理的证据和/或缺乏证据，并确定了研究的关键领域，以解决管理中面临的挑战痛风和 CKD。这些讨论涉及一般研究领域以及与用于治疗痛风发作或作为 ULT 的特定药物相关的研究领域，得到单独发表的 G-CAN 系统文献综述的支持。本共识声明并非旨在作为 CKD 痛风管理的指南；相反，它分析了有关用于痛风管理的药物的安全性和有效性的现有文献，以确定知识和相关研究领域的重要差距。<button class="bp3-button bp3-minimal bp3-small" style="color: #182026;" title="朗读" type="button"></button></p> </div> </div> </div> </div> </div> <div class="external-translators" style="color: #182026;"> <div> </div> </div>, tagList=[TagDto(tagId=2527, tagName=慢性肾脏病)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌科, tenant=100), CategoryDto(categoryId=14, categoryName=肾内科, tenant=100), CategoryDto(categoryId=15, categoryName=风湿免疫科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=2527, guiderKeyword=慢性肾脏病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=13547, appHits=394, showAppHits=0, pcHits=1148, showPcHits=13147, likes=2, shares=34, comments=7, approvalStatus=1, publishedTime=Mon Aug 02 13:10:31 CST 2021, publishedTimeString=2021-07-30, pcVisible=1, appVisible=1, editorId=5552845, editor=_Shirley_, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=4, createdBy=null, createdName=qiushida2, createdTime=Mon Aug 02 00:42:38 CST 2021, updatedBy=5552845, updatedName=_Shirley_, updatedTime=Sat Jan 06 21:35:16 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=慢性肾脏病痛风的管理.pdf)])

慢性肾脏病痛风的管理.pdf

下载请点击：

评论区 (5)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=1181812, encodeId=1b82118181224, content=有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f835602114, createdName=ms5000001407717875, createdTime=Fri Jan 07 12:47:37 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074576, encodeId=9cae10e4576b7, content=很不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=83d65159431, createdName=周倪, createdTime=Sat Nov 27 18:54:33 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061290, encodeId=5aa7106129002, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11de2204128, createdName=120bf7e7m98暂无昵称, createdTime=Sun Oct 17 20:06:39 CST 2021, time=2021-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055387, encodeId=d4e9105538e5e, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Mon Sep 27 15:29:01 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013434, encodeId=facb1013434ab, content=码一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKmlm5ZuVmbibPib0AzY8W6S1fhkWtVAxfqYKETSGV4WicQTkWYaSOXp3M2OBXyibcZz9tpIZkVsRV7Zw/132, createdBy=4bab5166347, createdName=ms6618406685645140, createdTime=Wed Sep 01 11:22:05 CST 2021, time=2021-09-01, status=1, ipAttribution=)]
2022-01-07 ms5000001407717875

有用

97 0
[GetPortalCommentsPageByObjectIdResponse(id=1181812, encodeId=1b82118181224, content=有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f835602114, createdName=ms5000001407717875, createdTime=Fri Jan 07 12:47:37 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074576, encodeId=9cae10e4576b7, content=很不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=83d65159431, createdName=周倪, createdTime=Sat Nov 27 18:54:33 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061290, encodeId=5aa7106129002, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11de2204128, createdName=120bf7e7m98暂无昵称, createdTime=Sun Oct 17 20:06:39 CST 2021, time=2021-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055387, encodeId=d4e9105538e5e, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Mon Sep 27 15:29:01 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013434, encodeId=facb1013434ab, content=码一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKmlm5ZuVmbibPib0AzY8W6S1fhkWtVAxfqYKETSGV4WicQTkWYaSOXp3M2OBXyibcZz9tpIZkVsRV7Zw/132, createdBy=4bab5166347, createdName=ms6618406685645140, createdTime=Wed Sep 01 11:22:05 CST 2021, time=2021-09-01, status=1, ipAttribution=)]
2021-11-27 周倪

很不错

110 0
[GetPortalCommentsPageByObjectIdResponse(id=1181812, encodeId=1b82118181224, content=有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f835602114, createdName=ms5000001407717875, createdTime=Fri Jan 07 12:47:37 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074576, encodeId=9cae10e4576b7, content=很不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=83d65159431, createdName=周倪, createdTime=Sat Nov 27 18:54:33 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061290, encodeId=5aa7106129002, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11de2204128, createdName=120bf7e7m98暂无昵称, createdTime=Sun Oct 17 20:06:39 CST 2021, time=2021-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055387, encodeId=d4e9105538e5e, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Mon Sep 27 15:29:01 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013434, encodeId=facb1013434ab, content=码一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKmlm5ZuVmbibPib0AzY8W6S1fhkWtVAxfqYKETSGV4WicQTkWYaSOXp3M2OBXyibcZz9tpIZkVsRV7Zw/132, createdBy=4bab5166347, createdName=ms6618406685645140, createdTime=Wed Sep 01 11:22:05 CST 2021, time=2021-09-01, status=1, ipAttribution=)]
2021-10-17 120bf7e7m98暂无昵称

不错

87 0
[GetPortalCommentsPageByObjectIdResponse(id=1181812, encodeId=1b82118181224, content=有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f835602114, createdName=ms5000001407717875, createdTime=Fri Jan 07 12:47:37 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074576, encodeId=9cae10e4576b7, content=很不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=83d65159431, createdName=周倪, createdTime=Sat Nov 27 18:54:33 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061290, encodeId=5aa7106129002, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11de2204128, createdName=120bf7e7m98暂无昵称, createdTime=Sun Oct 17 20:06:39 CST 2021, time=2021-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055387, encodeId=d4e9105538e5e, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Mon Sep 27 15:29:01 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013434, encodeId=facb1013434ab, content=码一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKmlm5ZuVmbibPib0AzY8W6S1fhkWtVAxfqYKETSGV4WicQTkWYaSOXp3M2OBXyibcZz9tpIZkVsRV7Zw/132, createdBy=4bab5166347, createdName=ms6618406685645140, createdTime=Wed Sep 01 11:22:05 CST 2021, time=2021-09-01, status=1, ipAttribution=)]
2021-09-27 13f0c37dm61暂无昵称

很好

106 0
[GetPortalCommentsPageByObjectIdResponse(id=1181812, encodeId=1b82118181224, content=有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f835602114, createdName=ms5000001407717875, createdTime=Fri Jan 07 12:47:37 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074576, encodeId=9cae10e4576b7, content=很不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=83d65159431, createdName=周倪, createdTime=Sat Nov 27 18:54:33 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061290, encodeId=5aa7106129002, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11de2204128, createdName=120bf7e7m98暂无昵称, createdTime=Sun Oct 17 20:06:39 CST 2021, time=2021-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055387, encodeId=d4e9105538e5e, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Mon Sep 27 15:29:01 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013434, encodeId=facb1013434ab, content=码一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKmlm5ZuVmbibPib0AzY8W6S1fhkWtVAxfqYKETSGV4WicQTkWYaSOXp3M2OBXyibcZz9tpIZkVsRV7Zw/132, createdBy=4bab5166347, createdName=ms6618406685645140, createdTime=Wed Sep 01 11:22:05 CST 2021, time=2021-09-01, status=1, ipAttribution=)]
2021-09-01 ms6618406685645140

码一下

144 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

内分泌科指南

2021 G-CAN 共识声明：慢性肾脏病痛风的管理

相关指南

拓展阅读

科室

工具

服务